Press Release: Galapagos : NecstGen Partners with Galapagos to Advance Decentralised CAR-T Cell Manufacturing in Europe
NecstGen, a leading Contract Development and Manufacturing Organization (CDMO) dedicated to Cell and Gene Therapies, announces a collaboration with Galapagos NV LEIDEN, NETHERLANDS, February 10, 2025 /EINPresswire.com/ -- NecstGen, a leading Contract ...
Read full article »
Galapagos is a Belgium-based biotechnology company that discovers, develops and commercializes small molecule medicines to the treatment of inflammatory and fibrotic diseases.
Read more